In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70% control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Control rates among people with hypertension in 2019 were 23% (20–27) for women and 18% (16–21) for men. Globally, 59% (55–62) of women and 49% (46–52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43–51) of women and 38% (35–41) of men were treated. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. The number of people aged 30–79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306–359) million women and 317 (292–344) million men in 1990 to 626 (584–668) million women and 652 (604–698) million men in 2019, despite stable global age-standardised prevalence. The Lancet Regional Health – Western Pacific.The Lancet Regional Health – Southeast Asia.The Lancet Gastroenterology & Hepatology.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |